Beijing-based CIMG Inc., a digital health and sales development firm, announced the completion of a significant transaction. The company sold 220 million shares of its common stock at $0.25 per share, generating $55 million in gross proceeds. Payment was received in 500 Bitcoin.
The company’s board of directors explained that accepting Bitcoin aligns with its financial strategy. The firm intends to maintain a long-term Bitcoin holding strategy, building a sizable reserve as a foundation for investor value.
Wang Jianshuang, CIMG‘s Chairwoman and CEO, commented on the growing acceptance of Bitcoin, suggesting that it creates opportunities for established businesses to become involved in the blockchain ecosystem. She emphasized CIMG‘s intention to be a leader in Bitcoin-related financial applications.
Wang Jianshuang also noted the company’s future plans to expand its digital asset holdings and pursue collaborations within the artificial intelligence and cryptocurrency industries, citing Merlin Chain as a potential partner.
CIMG Inc. is a multinational business group specializing in digital health and sales development. It leverages technology and marketing to increase sales and commercial value for its partners. Its portfolio of brands includes Kangduoyuan, Maca-Noni, Qianmao, Huomao, and Coco-mango.
The company’s press release included a statement regarding forward-looking statements. The company acknowledged that actual results may differ from expectations due to various factors, such as market conditions, regulatory changes, competition, and other business risks. Investors were encouraged to review the company’s filings with the Securities and Exchange Commission for more detailed information.
The stock sale was conducted as a private placement, exempt from registration under the Securities Act of 1933, and was not offered or sold in the United States except under applicable exemptions. The press release also clarified that it did not constitute an offer to sell or a solicitation to buy securities.
Related
